PT  - JOURNAL ARTICLE
AU  - Kim, Dasom
AU  - Jo, Jisoo
AU  - Lim, Jun-Sik
AU  - Ryu, Sukhyun
TI  - Serial interval and basic reproduction number of SARS-CoV-2 Omicron variant in South Korea
AID  - 10.1101/2021.12.25.21268301
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.25.21268301
4099  - http://medrxiv.org/content/early/2021/12/25/2021.12.25.21268301.short
4100  - http://medrxiv.org/content/early/2021/12/25/2021.12.25.21268301.full
AB  - South Korea is experiencing the community transmission of the SARS-CoV-2 Omicron variant (B.1.1.529). We estimated that the mean (± standard deviation) serial interval was 2.22 (± 1.62) days, and the basic reproduction number was 1.90 (95% Credible Interval, 1.50–2.43) for the Omicron variant outbreak in South Korea.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Basic Science Research Program through the National Research Foundation of Korea by the Ministry of Education (NRF-2020R1I1A3066471).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from Korea Centers for Disease Control and Prevention Agency. https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015 (17 December 2021, date last accessed).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors